Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03751436 · COMPLETED

Trial details

NCT number: NCT03751436
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Progression Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2019-08-02
Primary completion: 2022-07-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.